{
    "organizations": [],
    "uuid": "787c865221622157b0c6ded1820b6ddd72906adb",
    "author": "",
    "url": "https://www.reuters.com/article/brief-synlogic-doses-first-subject-in-ph/brief-synlogic-doses-first-subject-in-phase-1-2a-trial-of-synb1618-for-treatment-of-phenylketonuria-idUSASC09W92",
    "ord_in_thread": 0,
    "title": "BRIEF-Synlogic Doses First Subject In Phase 1/2A Trial Of Synb1618 For Treatment Of Phenylketonuria",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 10 AM / Updated 10 minutes ago BRIEF-Synlogic Doses First Subject In Phase 1/2A Trial Of Synb1618 For Treatment Of Phenylketonuria Reuters Staff \nApril 18 (Reuters) - Synlogic Inc: \n* SYNLOGIC DOSES FIRST SUBJECT IN PHASE 1/2A TRIAL OF SYNB1618 FOR TREATMENT OF PHENYLKETONURIA \n* SYNLOGIC INC - SECOND SYNTHETIC BIOTIC PROGRAM TO MOVE INTO CLINICAL STUDIES IN 2018 \n* SYNLOGIC INC - INTERIM DATA FROM SYNB1618 STUDY EXPECTED IN 2018; FULL DATA IN 2019 Source text for Eikon: Further company coverage:",
    "published": "2018-04-18T14:09:00.000+03:00",
    "crawled": "2018-04-18T14:34:34.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "dos",
        "first",
        "subject",
        "phase",
        "trial",
        "synb1618",
        "treatment",
        "phenylketonuria",
        "reuters",
        "staff",
        "april",
        "reuters",
        "synlogic",
        "inc",
        "synlogic",
        "dos",
        "first",
        "subject",
        "phase",
        "trial",
        "synb1618",
        "treatment",
        "phenylketonuria",
        "synlogic",
        "inc",
        "second",
        "synthetic",
        "biotic",
        "program",
        "move",
        "clinical",
        "study",
        "synlogic",
        "inc",
        "interim",
        "data",
        "synb1618",
        "study",
        "expected",
        "full",
        "data",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}